{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T14:44:03Z","timestamp":1761489843071},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2015,11,19]],"date-time":"2015-11-19T00:00:00Z","timestamp":1447891200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"OGAC, NIH and HRSA","award":["5R24TW008886"],"award-info":[{"award-number":["5R24TW008886"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drugs R D"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1007\/s40268-015-0110-z","type":"journal-article","created":{"date-parts":[[2015,11,19]],"date-time":"2015-11-19T09:18:30Z","timestamp":1447924710000},"page":"351-362","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Trimester-Specific Population Pharmacokinetics and Other Correlates of Variability in Sulphadoxine\u2013Pyrimethamine Disposition Among Ugandan Pregnant Women"],"prefix":"10.1007","volume":"15","author":[{"given":"Charles O.","family":"Odongo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kuteesa R.","family":"Bisaso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad","family":"Ntale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gordon","family":"Odia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francis W.","family":"Ojara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josaphat","family":"Byamugisha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jackson K.","family":"Mukonzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Celestino","family":"Obua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,11,19]]},"reference":[{"key":"110_CR1","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S1473-3099(07)70021-X","volume":"7","author":"M Desai","year":"2007","unstructured":"Desai M, ter Kuile FO, Nosten F, McGready R, Asamoa K, et al. Epidemiology and burden of malaria in pregnancy. Lancet Infect Dis. 2007;7:93\u2013104.","journal-title":"Lancet Infect Dis."},{"key":"110_CR2","doi-asserted-by":"crossref","first-page":"e1000221","DOI":"10.1371\/journal.pmed.1000221","volume":"7","author":"S Dellicour","year":"2010","unstructured":"Dellicour S, Tatem A, Guerra C, Snow R, ter Kuile FO. Quantifying the number of pregnancies at risk of malaria in 2007: a demographic study. PLoS Med. 2010;7:e1000221.","journal-title":"PLoS Med."},{"key":"110_CR3","unstructured":"World Health Organization (WHO). A strategic framework for malaria prevention and control during pregnancy in the African region. Brazaville: WHO Regional Offices for Africa; 2004."},{"key":"110_CR4","unstructured":"World Health Organization (WHO). World malaria report 2012. Geneva: WHO; 2013."},{"key":"110_CR5","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1475-2875-6-16","volume":"6","author":"A Vallely","year":"2007","unstructured":"Vallely A, Vallely L, Changalucha J, Greenwood B, Chandramohan D. Intermittent preventive treatment for malaria in pregnancy in Africa: what\u2019s new, what\u2019s needed? Malar J. 2007;6:16.","journal-title":"Malar J."},{"issue":"2","key":"110_CR6","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/S1473-3099(07)70024-5","volume":"7","author":"C Menendez","year":"2007","unstructured":"Menendez C, D\u2019Alessandro U, ter Kuile FO. Reducing the burden of malaria in pregnancy by preventive strategies. Lancet Infect Dis. 2007;7(2):126\u201335.","journal-title":"Lancet Infect Dis."},{"issue":"1","key":"110_CR7","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.1371\/journal.pmed.0020003","volume":"2","author":"NJ White","year":"2005","unstructured":"White NJ. Intermittent presumptive treatment for malaria. PLoS Med. 2005;2(1):e3.","journal-title":"PLoS Med."},{"key":"110_CR8","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1186\/1475-2875-11-424","volume":"11","author":"WHO Malaria Policy Advisory Committee and Secretariat","year":"2012","unstructured":"WHO Malaria Policy Advisory Committee and Secretariat. Malaria Policy Advisory Committee to the WHO: conclusions and recommendations of September 2012 meeting. Malar J. 2012;11:424.","journal-title":"Malar J."},{"issue":"9","key":"110_CR9","doi-asserted-by":"crossref","first-page":"e1001734","DOI":"10.1371\/journal.pmed.1001734","volume":"11","author":"RW Steketee","year":"2014","unstructured":"Steketee RW. Malaria prevention during pregnancy\u2014is there a next step forward? PLoS Med. 2014;11(9):e1001734.","journal-title":"PLoS Med."},{"issue":"1 Suppl","key":"110_CR10","doi-asserted-by":"crossref","first-page":"2","DOI":"10.4269\/ajtmh.1996.55.2","volume":"55","author":"RW Steketee","year":"1996","unstructured":"Steketee RW, Wirima JJ, Slutsker L, Heymann DL, Breman JG. The problem of malaria and malaria control in pregnancy in sub-Saharan Africa. Am J Trop Med Hyg. 1996;55(1 Suppl):2\u20137.","journal-title":"Am J Trop Med Hyg"},{"issue":"4","key":"110_CR11","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1093\/infdis\/jiq072","volume":"203","author":"A Kapito-Tembo","year":"2011","unstructured":"Kapito-Tembo A, Meshnick SR, van Hensbroek MB, Phiri K, Fitzgerald M, Mwapasa V. Marked reduction in prevalence of malaria parasitemia and anemia in HIV-infected pregnant women taking cotrimoxazole with or without sulfadoxine\u2013pyrimethamine intermittent preventive therapy during pregnancy in Malawi. J Infect Dis. 2011;203(4):464\u201372.","journal-title":"J Infect Dis."},{"issue":"6","key":"110_CR12","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1001\/jama.2012.216231","volume":"309","author":"K Kayentao","year":"2013","unstructured":"Kayentao K, Garner P, Eijk AM, Naidoo I, Roper C, Mulokozi A, et al. Intermittent preventive therapy for malaria during pregnancy using 2 vs\u00a03 or more doses of sulfadoxine\u2013pyrimethamine and the risk of low birth weight in Africa: systematic review and meta-analysis. J Am Med Assoc. 2013;309(6):594\u2013604.","journal-title":"J Am Med Assoc."},{"key":"110_CR13","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1001\/jama.297.23.2603","volume":"297","author":"FO Kuile ter","year":"2007","unstructured":"ter Kuile FO, Eijk AM, Filler SJ. Effect of sufadoxine\u2013pyrimethamine resistance on the efficacy of intermittent preventive therapy for malaria control during pregnancy: a systematic review. J Am Med Assoc. 2007;297:2603\u201316.","journal-title":"J Am Med Assoc."},{"key":"110_CR14","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1186\/1475-2875-13-227","volume":"13","author":"KR Tan","year":"2014","unstructured":"Tan KR, Katalenich BL, Mace KE, Nambozi M, Taylor SM, Meshnick SR, et al. Efficacy of sulphadoxine\u2013pyrimethamine for intermittent preventive treatment of malaria in pregnancy, Mansa, Zambia. Malar J. 2014;13:227.","journal-title":"Malar J."},{"issue":"8","key":"110_CR15","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1086\/591944","volume":"198","author":"CA Clerk","year":"2008","unstructured":"Clerk CA, Bruce J, Affipunguh PK, Mensah N, Hodgson A, Greenwood B, et al. A randomized, controlled trial of intermittent preventive treatment with sulfadoxine\u2013pyrimethamine, amodiaquine, or the combination in pregnant women in Ghana. J Infect Dis. 2008;198(8):1202\u201311.","journal-title":"J Infect Dis."},{"issue":"6","key":"110_CR16","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1093\/infdis\/jit276","volume":"208","author":"J Gutman","year":"2013","unstructured":"Gutman J, Mwandama D, Wiegand RE, Ali D, Mathanga DP, Skarbinski J. Effectiveness of intermittent preventive treatment with sulfadoxine\u2013pyrimethamine during pregnancy on maternal and birth outcomes in Machinga district, Malawi. J Infect Dis. 2013;208(6):907\u201316.","journal-title":"J Infect Dis."},{"issue":"12","key":"110_CR17","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/S1473-3099(12)70222-0","volume":"12","author":"TP Eisele","year":"2012","unstructured":"Eisele TP, Larsen DA, Anglewicz PA, Keating J, Yukich J, Bennett A, et al. Malaria prevention in pregnancy, birthweight, and neonatal mortality: a meta-analysis of 32 national cross-sectional datasets in Africa. Lancet Infect Dis. 2012;12(12):942\u20139.","journal-title":"Lancet Infect Dis."},{"issue":"2","key":"110_CR18","doi-asserted-by":"crossref","first-page":"e9438","DOI":"10.1371\/journal.pone.0009438","volume":"5","author":"C Menendez","year":"2010","unstructured":"Menendez C, Bardaji A, Sigauque B, Sanz S, Aponte JJ, Mabunda S, et al. Malaria prevention with IPTp during pregnancy reduces neonatal mortality. PLoS One. 2010;5(2):e9438.","journal-title":"PLoS One."},{"issue":"7","key":"110_CR19","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1086\/500951","volume":"193","author":"D Francis","year":"2006","unstructured":"Francis D, Nsobya SL, Talisuna A, Yeka A, Kamya MR, Machekano R, et al. Geographic differences in antimalarial drug efficacy in Uganda are explained by differences in endemicity and not by known molecular markers of drug resistance. J Infect Dis. 2006;193(7):978\u201386.","journal-title":"J Infect Dis."},{"issue":"13","key":"110_CR20","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/S0020-7519(03)00199-1","volume":"33","author":"J Cox-Singh","year":"2003","unstructured":"Cox-Singh J, Lu HY, Davis TM, Ilett KF, Hackett LP, Matusop A, et al. Application of a multi-faceted approach for the assessment of treatment response in falciparum malaria: a study from Malaysian Borneo. Int J Parasitol. 2003;33(13):1545\u201352.","journal-title":"Int J Parasitol."},{"key":"110_CR21","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1186\/1475-2875-9-177","volume":"9","author":"AF Gasasira","year":"2010","unstructured":"Gasasira AF, Kamya MR, Ochong EO, Vora N, Achan J, Charlebois E, et al. Effect of trimethoprim\u2013sulphamethoxazole on the risk of malaria in HIV-infected Ugandan children living in an area of widespread antifolate resistance. Malar J. 2010;9:177.","journal-title":"Malar J."},{"issue":"5","key":"110_CR22","doi-asserted-by":"crossref","first-page":"766","DOI":"10.4269\/ajtmh.2010.08-0408","volume":"82","author":"S Malamba","year":"2010","unstructured":"Malamba S, Sandison T, Lule J, Reingold A, Walker J, Dorsey G, et al. Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase mutations and the use of trimethoprim\u2013sulfamethoxazole prophylaxis among persons infected with human immunodeficiency virus. Am J Trop Med Hyg. 2010;82(5):766\u201371.","journal-title":"Am J Trop Med Hyg."},{"issue":"2","key":"110_CR23","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/S1473-3099(07)70025-7","volume":"7","author":"SA Ward","year":"2007","unstructured":"Ward SA, Sevene EJ, Hastings IM, Nosten F, McGready R. Antimalarial drugs and pregnancy: safety, pharmacokinetics, and pharmacovigilance. Lancet Infect Dis. 2007;7(2):136\u201344.","journal-title":"Lancet Infect Dis."},{"issue":"11","key":"110_CR24","doi-asserted-by":"crossref","first-page":"705","DOI":"10.2165\/11594550-000000000-00000","volume":"50","author":"KJ Wilby","year":"2011","unstructured":"Wilby KJ, Ensom MH. Pharmacokinetics of antimalarials in pregnancy: a systematic review. Clin Pharmacokinet. 2011;50(11):705\u201323.","journal-title":"Clin Pharmacokinet."},{"key":"110_CR25","doi-asserted-by":"crossref","unstructured":"Nosten F, McGready R, d\u2019Alessandro U, Bonell A, Verhoeff F, Menendez C et al. Antimalarial drugs in pregnancy: a review. Curr Drug Saf. 2006;1(1):1\u201315.","DOI":"10.2174\/157488606775252584"},{"issue":"9","key":"110_CR26","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1086\/522632","volume":"196","author":"MD Green","year":"2007","unstructured":"Green MD, van Eijk AM, ter Kuile FO, Ayisi JG, Parise ME, Kager PA, et al. Pharmacokinetics of sulfadoxine\u2013pyrimethamine in HIV-infected and uninfected pregnant women in Western Kenya. J Infect Dis. 2007;196(9):1403\u20138.","journal-title":"J Infect Dis."},{"issue":"10","key":"110_CR27","doi-asserted-by":"crossref","first-page":"4368","DOI":"10.1128\/AAC.00335-09","volume":"53","author":"HA Karunajeewa","year":"2009","unstructured":"Karunajeewa HA, Salman S, Mueller I, Baiwog F, Gomorrai S, Law I, et al. Pharmacokinetic properties of sulfadoxine\u2013pyrimethamine in pregnant women. Antimicrob Agents Chemother. 2009;53(10):4368\u201376.","journal-title":"Antimicrob Agents Chemother."},{"key":"110_CR28","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1146\/annurev.pharmtox.37.1.269","volume":"37","author":"UA Meyer","year":"1997","unstructured":"Meyer UA, Zanger UM. Molecular mechanisms of genetic polymorphisms of drug metabolism. Ann Rev Pharmacol Toxicol. 1997;37:269\u201396.","journal-title":"Ann Rev Pharmacol Toxicol."},{"issue":"3","key":"110_CR29","first-page":"217","volume":"45","author":"B Sarikabhuti","year":"1988","unstructured":"Sarikabhuti B, Keschamrus N, Noeypatimanond S, Weidekamm E, Leimer R, Wernsdorfer W, et al. Plasma concentrations of sulfadoxine in healthy and malaria infected Thai subjects. Acta Trop. 1988;45(3):217\u201324.","journal-title":"Acta Trop."},{"issue":"2","key":"110_CR30","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/clpt.2009.177","volume":"87","author":"MM Nyunt","year":"2010","unstructured":"Nyunt MM, Adam I, Kayentao K, van Dijk J, Thuma P, Mauff K, et al. Pharmacokinetics of sulfadoxine and pyrimethamine in intermittent preventive treatment of malaria in pregnancy. Clin Pharmacol Ther. 2010;87(2):226\u201334.","journal-title":"Clin Pharmacol Ther."},{"key":"110_CR31","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3389\/fphar.2014.00065","volume":"5","author":"MM Costantine","year":"2014","unstructured":"Costantine MM. Physiologic and pharmacokinetic changes in pregnancy. Front Pharmacol. 2014;5:65.","journal-title":"Front Pharmacol."},{"issue":"5","key":"110_CR32","doi-asserted-by":"crossref","first-page":"328","DOI":"10.2165\/00003088-199733050-00002","volume":"33","author":"R Loebstein","year":"1997","unstructured":"Loebstein R, Lalkin A, Koren G. Pharmacokinetic changes during pregnancy and their clinical relevance. Clin Pharmacokinet. 1997;33(5):328\u201343.","journal-title":"Clin Pharmacokinet."},{"key":"110_CR33","volume-title":"Uganda national malaria control policy 2011","author":"National Malaria Control Program","year":"2011","unstructured":"National Malaria Control Program. Uganda national malaria control policy 2011. Kampala: Ministry of Health; 2011."},{"issue":"2","key":"110_CR34","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/00007691-198706000-00013","volume":"9","author":"Y Bergqvist","year":"1987","unstructured":"Bergqvist Y, Hjelm E, Rombo L. Sulfadoxine assay using capillary blood samples dried on filter paper\u2014suitable for monitoring of blood concentrations in the field. Ther Drug Monit. 1987;9(2):203\u20137.","journal-title":"Ther Drug Monit."},{"issue":"1","key":"110_CR35","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jchromb.2004.10.049","volume":"814","author":"OM Minzi","year":"2005","unstructured":"Minzi OM, Massele AY, Gustafsson LL, Ericsson O. Simple and cost-effective liquid chromatographic method for determination of pyrimethamine in whole blood samples dried on filter paper. J Chromatograp B. 2005;814(1):179\u201383.","journal-title":"J Chromatograp B."},{"key":"110_CR36","doi-asserted-by":"crossref","first-page":"118","DOI":"10.2307\/2684123","volume":"34","author":"SL Beal","year":"1980","unstructured":"Beal SL, Sheiner LB. The NONMEM system. Am Stat. 1980;34:118\u20139.","journal-title":"Am Stat."},{"key":"110_CR37","volume-title":"NONMEM users guides","author":"AJ Boeckmann","year":"1994","unstructured":"Boeckmann AJ, Sheiner LB, Beal SL. NONMEM users guides. San Francisco: NONMEM Project Group, University of California; 1994."},{"issue":"2","key":"110_CR38","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.cmpb.2003.11.003","volume":"75","author":"L Lindbom","year":"2004","unstructured":"Lindbom L, Ribbing J, Jonsson EN. Perl-speaks-NONMEM (PsN)\u2014a Perl module for NONMEM related programming. Comput Methods Programs Biomed. 2004;75(2):85\u201394.","journal-title":"Comput Methods Programs Biomed."},{"key":"110_CR39","unstructured":"R Core Team. R: a language and environment for statistical computing. Version 3.0.1. Vienna: R Foundation for Statistical Computing; 2013."},{"key":"110_CR40","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0169-2607(98)00067-4","volume":"58","author":"EN Jonsson","year":"1999","unstructured":"Jonsson EN, Karlson MO. Xpose\u2014an S-Plus based population pharmacokinetic\/pharmacodynamic model building aid for NONMEM. Comput Methods Programs Biomed. 1999;58:51\u201364.","journal-title":"Comput Methods Programs Biomed."},{"issue":"6","key":"110_CR41","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1177\/0091270003253624","volume":"43","author":"EI Ette","year":"2003","unstructured":"Ette EI, Williams PJ, Kim YH, Lane JR, Liu MJ, Capparelli EV. Model appropriateness and population pharmacokinetic modeling. J Clin Pharmacol. 2003;43(6):610\u201323.","journal-title":"J Clin Pharmacol."},{"issue":"9","key":"110_CR42","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1093\/clinchem\/35.9.1978","volume":"35","author":"CK Cheung","year":"1989","unstructured":"Cheung CK, Lao T, Swaminathan R. Urinary excretion of some proteins and enzymes during normal pregnancy. Clin Chem. 1989;35(9):1978\u201380.","journal-title":"Clin Chem."},{"key":"110_CR43","volume-title":"Systematic search and analysis of published pharmacokinetic data related to sulfadoxine","author":"C Bruno","year":"2005","unstructured":"Bruno C, Rodolphe T, Rachid SL. Systematic search and analysis of published pharmacokinetic data related to sulfadoxine. Bordeaux: European Toxo Prevention Group; 2005."},{"key":"110_CR44","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1111\/j.1471-0528.1963.tb04922.x","volume":"70","author":"FE Hytten","year":"1963","unstructured":"Hytten FE, Paintin DB. Increase in plasma volume during normal pregnancy. J Obstet Gynaecol. 1963;70:402\u20137.","journal-title":"J Obstet Gynaecol."},{"key":"110_CR45","volume-title":"Fansidar (sulfadoxine\u2013pyrimethamine) tablets: prescribing information","author":"Roche Laboratories","year":"2004","unstructured":"Roche Laboratories. Fansidar (sulfadoxine\u2013pyrimethamine) tablets: prescribing information. Nutley: Roche Laboratories; 2004."},{"key":"110_CR46","doi-asserted-by":"crossref","unstructured":"Preissner S, Kroll K, Dunkel M, Senger C, Goldsobel G, Kuzman D et al. SuperCYP: a comprehensive database on cytochrome P450 enzymes including a tool for analysis of CYP\u2013drug interactions. Nucleic Acids Research. 2010;38(Database Issue):D237\u201343.","DOI":"10.1093\/nar\/gkp970"},{"issue":"6","key":"110_CR47","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/clpt.1985.114","volume":"37","author":"S Hogstedt","year":"1985","unstructured":"Hogstedt S, Lindberg B, Peng DR, Regardh CG, Rane A. Pregnancy-induced increase in metoprolol metabolism. Clin Pharmacol Ther. 1985;37(6):688\u201392.","journal-title":"Clin Pharmacol Ther."},{"issue":"3","key":"110_CR48","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0920-1211(90)90042-T","volume":"5","author":"MS Yerby","year":"1990","unstructured":"Yerby MS, Friel PN, McCormick K, Koerner M, Van Allen M, Leavitt AM, et al. Pharmacokinetics of anticonvulsants in pregnancy: alterations in plasma protein binding. Epilepsy Res. 1990;5(3):223\u20138.","journal-title":"Epilepsy Res."},{"issue":"6","key":"110_CR49","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1046\/j.1365-2958.1999.01437.x","volume":"32","author":"P Wang","year":"1999","unstructured":"Wang P, Brobey RK, Horii T, Sims PF, Hyde JE. Utilization of exogenous folate in the human malaria parasite Plasmodium falciparum and its critical role in antifolate drug synergy. Mol Microbiol. 1999;32(6):1254\u201362.","journal-title":"Mol Microbiol."},{"issue":"12","key":"110_CR50","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S0169-4758(97)01124-1","volume":"13","author":"WM Watkins","year":"1997","unstructured":"Watkins WM, Mberu EK, Winstanley PA, Plowe CV. The efficacy of antifolate antimalarial combinations in Africa: a predictive model based on pharmacodynamic and pharmacokinetic analyses. Parasitol Today. 1997;13(12):459\u201364.","journal-title":"Parasitol Today."},{"issue":"2","key":"110_CR51","doi-asserted-by":"crossref","first-page":"239","DOI":"10.4269\/ajtmh.1986.35.239","volume":"35","author":"A Schapira","year":"1986","unstructured":"Schapira A, Bygbjerg IC, Jepsen S, Flachs H, Bentzon MW. The susceptibility of Plasmodium falciparum to sulfadoxine and pyrimethamine: correlation of in\u00a0vivo and in\u00a0vitro results. Am J Trop Med Hyg. 1986;35(2):239\u201345.","journal-title":"Am J Trop Med Hyg."},{"key":"110_CR52","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1475-2875-11-39","volume":"11","author":"J Gutman","year":"2012","unstructured":"Gutman J, Kachur SP, Slutsker L, Nzila A, Mutabingwa T. Combination of probenecid\u2013sulphadoxine\u2013pyrimethamine for intermittent preventive treatment in pregnancy. Malar J. 2012;11:39.","journal-title":"Malar J."}],"container-title":["Drugs in R&D"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40268-015-0110-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40268-015-0110-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40268-015-0110-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,11]],"date-time":"2020-09-11T15:30:00Z","timestamp":1599838200000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40268-015-0110-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11,19]]},"references-count":52,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["110"],"URL":"https:\/\/doi.org\/10.1007\/s40268-015-0110-z","relation":{},"ISSN":["1174-5886","1179-6901"],"issn-type":[{"value":"1174-5886","type":"print"},{"value":"1179-6901","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,19]]}}}